Start: 08 Nov 2021, 15:45
End: 08 Nov 2021, 16:45

Chair: Professor Richard Wilson, University of Glasgow, UK


Abstract title: Primary results of phase 2 FOENIX-CCA2: the irreversible FGFR1–4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements
Presenting author: John Bridgewater

Abstract title: Outcomes of patients with confirmed cancer of unknown primary: a 10-year analysis
Presenting author: Mark Stares

Abstract title: SELIMETRY: resensitising iodine refractory differentiated thyroid cancer to radioiodine
Presenting author: Jon Wadsley

Session labels:

Allied Health Professionals Clinical trials Clinicians Gastrointestinal Live Liver Living with and beyond cancer Nurses Patient experts Primary Care Physicians Proffered papers Scientists Students Surgeons Trainees / Early career researchers Treatment